SCHEMBL14520965

SCHEMBL14520965

CC(=O)N1CCC(c2ccccc2)(c2nn[nH]n2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET3 O43151 4/20 0.72
KMT2A Q03164 4/20 0.72
FBXL19 Q6PCT2 4/20 0.72
TET1 Q8NFU7 4/20 0.72
KDM2B Q8NHM5 4/20 0.72
CXXC4 Q9H2H0 4/20 0.72
KDM2A Q9Y2K7 4/20 0.72
CXXC5 Q7LFL8 3/20 0.72
OPRD1 P41143 1/20 0.48
OPRK1 P41145 1/20 0.48
OPRM1 P35372 1/20 0.45
USP2 O75604 2/20 0.44
ALDH1A1 P00352 4/20 0.43
CYP2C19 P33261 3/20 0.43
MAPK1 P28482 2/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
LPAR1 Q92633 1/20 0.42
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2526026 0.83 TET3 (0.64) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL14520963 0.77 OPRD1 (0.48) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL12216179 0.76 KMT2A (0.54) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL2529201 0.75 KMT2A (0.57) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL31147394 0.75 KMT2A (0.59) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL2526312 0.75 OPRM1 (0.59) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL2527305 0.74 CYP2C19 (0.55) TET3KMT2AFBXL19TET1KDM2B
Hydrochloric Acid SCHEMBL2529676 0.74 OPRM1 (0.58) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL14520964 0.73 KMT2A (0.49) TET3KMT2AFBXL19TET1KDM2B
SCHEMBL27645407 0.73 KMT2A (0.55) TET3KMT2AFBXL19TET1KDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070088036-A1 Piperidine derivatives and methods of use CHEMOCENTRYX, INC. (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088036-A1 Piperidine derivatives and methods of use CCR1, CCR3, CCR4 TET3 4570/4885KMT2A 4268/4885FBXL19 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.